Company Filing History:
Years Active: 1999-2024
Title: Nathaniel R. Landau: Innovator in Viral Research
Introduction
Nathaniel R. Landau is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of viral research. He holds a total of 6 patents, showcasing his innovative approach to addressing critical health challenges.
Latest Patents
One of his latest patents is the Angiotensin-converting enzyme 2 (ACE2) immunoadhesin microbody. This invention provides polypeptides that comprise an enzymatically inactive ACE2 ectodomain, a segment of an immunoglobulin Fc, and optionally a purification tag. The patent also includes a cDNA or an expression vector encoding the polypeptide, along with a method for culturing cells that utilize the expression vector. Furthermore, it offers a method for prophylaxis or therapy for Coronavirus infections by administering the polypeptide to individuals in need. Another notable patent is the Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism. This invention relates to lentiviral vectors that can generate virions exhibiting enhanced infectivity with respect to monocyte-derived macrophages and dendritic cells. The compositions and methods described can be utilized in the production of virions that serve as components of vaccines, effectively stimulating innate immune responses.
Career Highlights
Throughout his career, Nathaniel R. Landau has worked with esteemed institutions such as New York University and the Aaron Diamond AIDS Research Center. His work has significantly advanced the understanding of viral mechanisms and potential therapeutic approaches.
Collaborations
Nathaniel has collaborated with notable colleagues, including Rong Liu and Dan R. Littman, contributing to a rich exchange of ideas and innovations in the field of virology.
Conclusion
Nathaniel R. Landau's innovative work in viral research and his numerous patents highlight his commitment to advancing medical science. His contributions continue to play a vital role in the fight against viral infections.